Press "Enter" to skip to content

Biosimilars Market size is projected to reach USD 55.41 billion in 2028 at a 28.4% CAGR – Introspective Market Research



Market Overview: 

Biosimilars Market size is projected to reach USD 55.41 billion in 2028 from an estimated USD 9.63 billion in 2021, growing at a CAGR of 28.4% globally.

Global Biosimilars Market by Product Type, Application (Growth Hormonal Deficiency, Oncology, Blood Disorders, Chronic And Autoimmune Disorders, And Others), and Region – Forecast to 2028

The Biosimilars market study insights provides a comprehensive analysis on industry size and forecasts, technology trends, growth drivers, and industry challenges, as well as a key players analysis that covers leading key players. The Biosimilars Market report provides the Industry scope, overview, value chain analysis, market sizing, segment and sub segment analysis, and forecast.

Leading Key Players Covered in Biosimilars industry:

Novartis AG (Switzerland), Pfizer Inc. (US), Dr. Reddy’s Laboratories Ltd. (India), Amgen Inc. (US), Eli Lilly and Company (US), Teva Pharmaceutical Industries Ltd. (Israel), Fresenius SE & Co. KGaA (Germany), STADA Arzneimittel AG (Germany), Boehringer Ingelheim (Germany), Gedeon Richter PLC (Hungary), Celltrion (South Korea), Samsung Biologics (South Korea), Coherus BioSciences (US), Biocon Limited (India), Viatris Inc. (US), Amega Biotech (Argentina), Apotex Inc. (Canada), Biocad (Russia), mAbxience (Spain), Probiomed S.A. De C.V. (Mexico), Fujifilm Kyowa Kirin Biologics Co. Ltd. (Japan), Intas Pharmaceuticals Ltd. (India), Thermex (UK), Reliance Life Sciences (India), Kashiv Biosciences (US) ,

Access PDF Sample Copy @

The research study will cover a detailed porter’s five forces analysis containing the bargaining power of suppliers, bargaining power of buyers, threat of new entrants, threat of substitutes, competitive rivalry, and market condition. Also, the research study provides the in depth industry value chain analysis, market dynamics, pestle analysis, technological roadmap, regulatory landscape, SWOT analysis, price trend and patent analysis.

Research provides an up-to-date analysis of the current market scenario, as well as the current developments, trends, growth factors and opportunities. Furthermore, the growing demand for Biosimilars is expected to propel the industry forward. The Biosimilars market analysis is segmented into type, application and regional analysis.

Also, the Biosimilars market report includes detailed study insights on upcoming technology trends, threats, restraints, challenges and opportunities that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

Market Segmentation

By Type, Biosimilars has been segmented into:      

  • Recombinant non-glycosylated proteins
  • human growth hormones
  • Granulocyte colony-stimulating factor (g-csf)
  • Interferons
  • Insulin
  • Recombinant glycosylated proteins
  • erythropoietin
  • Monoclonal antibodies
  • Follitropin

By Application, Biosimilars has been segmented into:      

  • Blood Disorders
  • Growth Hormonal Deficiency
  • Chronic and Autoimmune Disorders
  • Oncology
  • Other Applications

View the detailed Table of Content on Biosimilars Market

For this report, Introspective Market Research has segmented the Biosimilars Market based on region:

Regional Outlook (Revenue in USD Million; Volume in Units, 2022-2028)

  • North America (U.S., Canada, Mexico)
  • Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
  • Asia-Pacific (China, India, Japan, Southeast Asia etc.)
  • South America (Brazil, Argentina etc.)
  • Middle East & Africa (Saudi Arabia, South Africa etc.)

Be First to Comment

Leave a Reply

Your email address will not be published.